Democratic Republic of the Congo vs Solomon Islands: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Democratic Republic of the Congo
1.4%
in 2024
Solomon Islands
1.4%
in 2024
Democratic Republic of the Congo rank
22nd
Solomon Islands rank
22nd
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Democratic Republic of the Congo
- Solomon Islands
How they compare
Democratic Republic of the Congo currently reports 1.4% against 1.4% in Solomon Islands, a difference of 0.0%.
Across all 10 years both countries report, Solomon Islands has been ahead every year.
Democratic Republic of the Congo ranks 22nd and Solomon Islands ranks 22nd of 246 countries.
Solomon Islands has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Democratic Republic of the Congo | Solomon Islands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.5% | 2.1% | 0.6% | Solomon Islands |
| 2020s | 1.4% | 1.6% | 0.2% | Solomon Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Democratic Republic of the Congo or Solomon Islands?
- Democratic Republic of the Congo, at 1.4% against 1.4% in Solomon Islands as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Democratic Republic of the Congo and Solomon Islands?
- 0.0%, with Democratic Republic of the Congo ahead.
- How many years of comparable data are there for Democratic Republic of the Congo and Solomon Islands?
- 10 years are reported by both, from 2015 to 2024.
- How do Democratic Republic of the Congo and Solomon Islands rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Democratic Republic of the Congo ranks 22nd and Solomon Islands ranks 22nd of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.